Themis Medicare Limited (THEMISMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-14.84 Million ≈ $-160.49K USD) by net assets (Rs3.80 Billion ≈ $41.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see THEMISMED stock market capitalisation for the company's overall valuation and market capitalisation.
Themis Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Themis Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Themis Medicare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Themis Medicare Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Themis Medicare Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Silk Logistics Holdings Ltd
AU:SLH
|
0.381x |
|
Trio-Tech International
NYSE MKT:TRT
|
0.004x |
|
Stomil Sanok SA
WAR:SNK
|
0.014x |
|
VivoPower PLC
NASDAQ:VIVO
|
N/A |
|
King Polytechnic Engineering Co Ltd
TWO:6122
|
0.110x |
|
Indo Kordsa Tbk
JK:BRAM
|
0.081x |
|
WTK Holdings Bhd
KLSE:4243
|
0.074x |
|
HB Technology CO.LTD
KQ:078150
|
0.041x |
Annual Cash Flow Conversion Efficiency for Themis Medicare Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Themis Medicare Limited from 2006 to 2025. View Themis Medicare Limited (THEMISMED) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs4.03 Billion ≈ $43.54 Million |
Rs347.10 Million ≈ $3.75 Million |
0.086x | +47.37% |
| 2024-03-31 | Rs3.78 Billion ≈ $40.84 Million |
Rs220.94 Million ≈ $2.39 Million |
0.059x | +23.40% |
| 2023-03-31 | Rs3.39 Billion ≈ $36.71 Million |
Rs160.93 Million ≈ $1.74 Million |
0.047x | -60.37% |
| 2022-03-31 | Rs2.87 Billion ≈ $31.09 Million |
Rs343.94 Million ≈ $3.72 Million |
0.120x | -54.12% |
| 2021-03-31 | Rs2.19 Billion ≈ $23.63 Million |
Rs569.75 Million ≈ $6.16 Million |
0.261x | +14440.88% |
| 2020-03-31 | Rs1.83 Billion ≈ $19.79 Million |
Rs3.28 Million ≈ $35.49K |
0.002x | -97.41% |
| 2019-03-31 | Rs1.58 Billion ≈ $17.09 Million |
Rs109.23 Million ≈ $1.18 Million |
0.069x | +48.70% |
| 2018-03-31 | Rs1.69 Billion ≈ $18.26 Million |
Rs78.47 Million ≈ $848.62K |
0.046x | +152.43% |
| 2017-03-31 | Rs1.20 Billion ≈ $13.03 Million |
Rs-106.78 Million ≈ $-1.15 Million |
-0.089x | -128.86% |
| 2016-03-31 | Rs788.89 Million ≈ $8.53 Million |
Rs242.32 Million ≈ $2.62 Million |
0.307x | +0.33% |
| 2015-03-31 | Rs589.08 Million ≈ $6.37 Million |
Rs180.34 Million ≈ $1.95 Million |
0.306x | +188.73% |
| 2014-03-31 | Rs561.85 Million ≈ $6.08 Million |
Rs59.57 Million ≈ $644.27K |
0.106x | +25.17% |
| 2013-03-31 | Rs537.17 Million ≈ $5.81 Million |
Rs45.51 Million ≈ $492.12K |
0.085x | +132.21% |
| 2012-03-31 | Rs580.79 Million ≈ $6.28 Million |
Rs-152.73 Million ≈ $-1.65 Million |
-0.263x | -639.73% |
| 2011-03-31 | Rs910.26 Million ≈ $9.84 Million |
Rs44.35 Million ≈ $479.64K |
0.049x | +16.28% |
| 2010-03-31 | Rs833.43 Million ≈ $9.01 Million |
Rs34.92 Million ≈ $377.67K |
0.042x | +145.22% |
| 2009-03-31 | Rs918.65 Million ≈ $9.93 Million |
Rs-85.13 Million ≈ $-920.63K |
-0.093x | -9.87% |
| 2008-03-31 | Rs845.93 Million ≈ $9.15 Million |
Rs-71.35 Million ≈ $-771.58K |
-0.084x | -184.24% |
| 2007-03-31 | Rs691.60 Million ≈ $7.48 Million |
Rs69.24 Million ≈ $748.82K |
0.100x | +155.05% |
| 2006-03-31 | Rs605.21 Million ≈ $6.55 Million |
Rs23.76 Million ≈ $256.92K |
0.039x | -- |
About Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic,… Read more